Jonatan Salzer

Umea, AC, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications

Internet-based vestibular rehabilitation versus written instructions after acute vertigo: A randomised controlled trial.

Internet-based vestibular rehabilitation versus written instructions after acute vertigo: A randomised controlled trial.

Journal: PloS one
Published: March 19, 2026

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing-Remitting MS.

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing-Remitting MS.

Journal: Annals of clinical and translational neurology
Published: December 19, 2025

The reliability and validity of the Swedish translation of the Vertigo Symptom Scale - short form in a cohort with acute vestibular syndrome.

The reliability and validity of the Swedish translation of the Vertigo Symptom Scale - short form in a cohort with acute vestibular syndrome.

Journal: Annals of medicine
Published: February 10, 2025

Dizziness and vertigo sick leave before and after insurance restrictions - a descriptive Swedish nationwide register linkage study.

Dizziness and vertigo sick leave before and after insurance restrictions - a descriptive Swedish nationwide register linkage study.

Journal: BMC public health
Published: July 09, 2024

Exploring strategies for management of in-hospital stroke in Sweden: A qualitative study.

Exploring strategies for management of in-hospital stroke in Sweden: A qualitative study.

Journal: PloS one
Published: April 26, 2024

COMBAT-MS: A Population-Based Observational Cohort Study Addressing the Benefit-Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab.

COMBAT-MS: A Population-Based Observational Cohort Study Addressing the Benefit-Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab.

Journal: Annals of neurology
Published: February 20, 2024

Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein-Barr Virus in MS Development: A Presymptomatic Case-Control Study.

Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein-Barr Virus in MS Development: A Presymptomatic Case-Control Study.

Journal: Annals of neurology
Published: January 30, 2024

Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study.

Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study.

Journal: European journal of neurology
Published: January 30, 2024

Rituximab treatment in pediatric-onset multiple sclerosis.

Rituximab treatment in pediatric-onset multiple sclerosis.

Journal: European journal of neurology
Published: September 08, 2023

Characteristics of in-hospital stroke patients in Sweden: A nationwide register-based study.

Characteristics of in-hospital stroke patients in Sweden: A nationwide register-based study.

Journal: European stroke journal
Published: June 17, 2023

Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy.

Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy.

Journal: Journal of neurology, neurosurgery, and psychiatry
Published: May 08, 2023

Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis.

Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis.

Journal: Brain : a journal of neurology
Published: February 23, 2023
Showing 1-12 of 63

Last Updated: 09/26/2026